Global Human Albumin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Human Albumin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.
Human Albumin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Albumin market is projected to reach US$ 6954 million in 2034, increasing from US$ 5132.1 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2034. Demand from Therapeutics and Drug Formulation & Vaccine are the major drivers for the industry.
Human albumin was initially used only as a volume replacement therapy; however, extensive research has shown that human albumin has numerous applications in other therapeutic areas as well. For instance, Grifols is exploring the use of the product to stabilize Alzheimer’s disease. Moreover, drugs containing human serum albumin, such as Levemir and Abraxane are used to treat diabetes and metastatic breast cancer, respectively. Furthermore, the on-going research and augmented adoption of albumin in the new therapeutic areas will boost this market’s growth during the predicted period.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion
Segment by Type
5% Concentrations
25% Concentrations
Others
Therapeutics
Drug Formulation & Vaccine
Component of Media
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Albumin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Human Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Albumin introduction, etc. Human Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Human Albumin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Albumin market is projected to reach US$ 6954 million in 2034, increasing from US$ 5132.1 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2034. Demand from Therapeutics and Drug Formulation & Vaccine are the major drivers for the industry.
Human albumin was initially used only as a volume replacement therapy; however, extensive research has shown that human albumin has numerous applications in other therapeutic areas as well. For instance, Grifols is exploring the use of the product to stabilize Alzheimer’s disease. Moreover, drugs containing human serum albumin, such as Levemir and Abraxane are used to treat diabetes and metastatic breast cancer, respectively. Furthermore, the on-going research and augmented adoption of albumin in the new therapeutic areas will boost this market’s growth during the predicted period.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion
Segment by Type
5% Concentrations
25% Concentrations
Others
Segment by Application
Therapeutics
Drug Formulation & Vaccine
Component of Media
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Albumin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Human Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Albumin introduction, etc. Human Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.